Page last updated: 2024-08-22

platinum and everolimus

platinum has been researched along with everolimus in 35 studies

Research

Studies (35)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's32 (91.43)24.3611
2020's3 (8.57)2.80

Authors

AuthorsStudies
Barry, JJ; Casey, MA; Feygin, JM; Huibregtse, BA; Pennington, DE; Soucy, NV; Tunstall, R1
Allocco, DJ; Dawkins, KD; El-Jack, S; Meredith, IT; Scott, D; Starzyk, RM; Stone, GW; Teirstein, PS; Whitbourn, R; Zambahari, R1
Calais, F; Carlsson, J; Götberg, M; James, S; Lagerqvist, B; Nilsson, J; Nilsson, T; Olivecrona, G; Sarno, G; Sjögren, I1
Cha, KS; Chae, IH; Hwang, KK; Jeon, HK; Jeong, MH; Kang, SH; Kim, HS; Kim, S; Kwon, HM; Lee, SP; Lee, SY; Moon, KW; Oh, JH; Park, BE; Park, JJ; Park, KW; Park, TH; Rhew, JY; Shin, ES; Yoon, JH1
Büttner, HJ; Gick, M; Leibundgut, G; Löffelhardt, N; Neumann, FJ; Toma, A; Valina, C1
De la Torre Hernandez, JM; Garcia Camarero, T; Gorria, GM; Lee, DH; Lerena, P; Sainz Laso, F; Zueco, J1
Allocco, DJ; Cannon, LA; Dawkins, KD; Dens, J; Dubois, CL; Feldman, RL; Lee, TC; Meredith, IT; Mooney, MR; Pompili, VJ; Rabinowitz, AC; Saito, S; Stone, GW; Teirstein, PS1
Choi, D; Hong, MK; Jang, Y; Kim, BK; Kim, JS; Ko, YG; Shin, DH1
Allocco, DJ; Dawkins, KD; Fang, Q; Gao, R; Han, Y; Hou, Y; Li, H; Wang, H; Xu, B; Yang, Y; Yu, B; Zhang, J1
Garcia-Garcia, HM; Karanasos, A; Regar, E; van Geuns, RJ1
Blumenschein, GR; Canales, JR; Ginsberg, LE; Heymach, JV; Kies, MS; Lee, JJ; Lin, H; Lu, C; Massarelli, E; Papadimitrakopoulou, V; Tran, HT; Williams, MD1
Chan, KH; Chan, M; Fang, WY; Lee, CH; Li, RG; Low, A; Qu, XK; Richards, AM; Tan, HC1
Ando, K; Domei, T; Enomoto, S; Hiromasa, T; Hyodo, M; Iwabuchi, M; Kuramitsu, S; Mazaki, T; Shinozaki, T; Shirai, S; Soga, Y; Yamaji, K1
Goto, K; Hagikura, A; Haruta, S; Takebayashi, H1
Airaksinen, JK; Karjalainen, PP; Kiviniemi, TO; Mikkelsson, J; Nammas, W; Perälä, A; Pietilä, M; Romppanen, H; Sia, J; Tuomainen, P; Varho, V1
Alard, A; Blank, SV; Curtin, JP; David-West, G; Musa, F; Schneider, RJ1
Elhadad, S; Fajadet, J; Hildick-Smith, D; Hovasse, T; Neumann, FJ; Petronio, S; Roberts, D; Silber, S; Spence, M; Valdés, M; Wöhrle, J; Zaman, A1
Arana, C; Dager, A; Delgado, JA; Gasior, P; Généreux, P; Granada, JF; Hernandez, H; Higuera, S; Maehara, A; Moncada, M; Vesga, B1
Byrne, RA; Cassese, S; Colleran, R; de Waha, A; Fusaro, M; Giacoppo, D; Harada, Y; Kastrati, A; Kufner, S; Laugwitz, KL; Ndrepepa, G; Rheude, T; Schunkert, H; Xhepa, E1
Boersma, E; Daemen, J; de Jaegere, PP; Diletti, R; Lemmert, ME; Regar, E; van Bommel, RJ; van Domburg, RT; van Geuns, RJ; van Mieghem, NM; Zijlstra, F1
Danielewicz, M; Hambraeus, K; James, S; Lagerqvist, B; Lindholm, D; Olivecrona, G; Råmunddal, T; Sarno, G; Varenhorst, C; Witt, N1
Allocco, DJ; Chen, J; Dawkins, KD; Fu, G; Han, Y; Hong, T; Jiang, T; Li, H; Liu, H; Pang, W; Su, X; Sun, F; Wang, H; Xu, K; Yang, Y; Yuan, Z; Zhang, J; Zhang, M1
Kirtane, AJ; Yancy, CW1
Ahn, T; Bae, JH; Cha, KS; Han, KR; Jeon, KH; Kang, HJ; Kim, HS; Kim, SH; Koo, BK; Kwon, HM; Lee, JM; Lee, MS; Oh, SK; Park, KW; Park, SH; Park, WJ; Rha, SW; Rhee, TM; Rhew, JY; Seung, KB1
Aizawa, Y; Fujita, S; Fuse, K; Hatada, K; Ikeda, Y; Kishi, S; Matsubara, T; Okabe, M; Sato, T; Takahashi, M1
Allocco, DJ; Bouchard, A; Carrié, D; Dawkins, KD; Dens, J; Dubois, CL; Farah, B; Feldman, RL; Hagiwara, N; Kelly, CR; Meredith, IT; Pompili, V; Rabinowitz, A; Saito, S; Stone, GW; Teirstein, PS1
Allocco, DJ; Christen, T; Crowley, J; Ferrario, M; Jung, W; Legrand, V; MacCarthy, P; Meredith, IT; Moreno, R; Redwood, S; Richardt, G; Schwimmbeck, P; Ungi, I; Werner, N; Zaman, A1
Benito Gonzalez, T; de la Torre Hernandez, JM; Escaned, J; Garcia Del Blanco, B; Gomez Menchero, A; Gonzalo, N; Hernandez, F; Linares, JA; Moreno, R; Rivera, R; Subinas, A; Veiga Fernandez, G1
Allocco, D; Aquino, M; Batchelor, W; Claessen, BE; Davis, S; Gigliotti, OS; Giugliano, G; Guedeney, P; Haghighat, A; Horwitz, PA; Kandzari, DE; Lopez, M; Mehran, R; Meredith, IT; Othman, I; Singh, S; Sorrentino, S; Tamis, L; Underwood, P; Wang, JC1
Fujii, K; Fujimoto, Y; Himi, T; Ishikawa, K; Kadohira, T; Kitahara, H; Kobayashi, Y; Oka, N; Sano, K; Takahara, M1
Allocco, DJ; Amjadi, N; Caputo, C; Chen, H; Kandzari, DE; Meredith, IT; Rowe, SK; Tamboli, HP; Underwood, PL; Williams, J1
Cha, KS; Chae, IH; Hur, SH; Hwang, KK; Jeon, HK; Jeong, MH; Kang, J; Kim, CH; Kim, HS; Kim, S; Kwon, HM; Lee, BR; Lee, SY; Moon, KW; Oh, JH; Park, BE; Park, KW; Park, TH; Park, YW; Rhew, JY; Ryu, JK; Shin, ES; Yoon, JH1
Asagi, A; Furukawa, M; Furuse, J; Hara, H; Hosokawa, A; Ikeda, M; Kojima, M; Kojima, Y; Mizuno, N; Murohisa, G; Ohkawa, S; Okusaka, T; Okuyama, H; Shioji, K; Yamanaka, T1
Anderson, R; Barragan, P; Bressollette, E; Chun-Chin, C; Hanratty, CG; Kretov, E; Lesiak, M; McEntegart, MB; Menown, I; Merkulov, E; O'Kane, P; Oldroyd, KG; Onuma, Y; Peace, A; Protopopov, A; Rocchiccioli, P; Silvestri, M; van Geuns, RJ; Wlodarczak, A1
Asano, T; Garg, S; Ishibashi, Y; Kageyama, S; Katagiri, Y; Kawashima, H; Kogame, N; Kotoku, N; Kozuma, K; Masuda, S; Miyazaki, Y; Morino, Y; Muramatsu, T; Nakamura, M; Nakatani, S; Nakazawa, G; Ninomiya, K; Okamura, T; Onuma, Y; Ozaki, Y; Serruys, PW; Takahashi, H; Takahashi, K; Tanabe, K; Tateishi, H; Tu, S1

Trials

14 trial(s) available for platinum and everolimus

ArticleYear
The 'Harmonizing Optimal Strategy for Treatment of coronary artery stenosis - sAfety & effectiveneSS of drug-elUting stents & antiplatelet REgimen' (HOST-ASSURE) trial: study protocol for a randomized controlled trial.
    Trials, 2012, Mar-31, Volume: 13

    Topics: Angioplasty, Balloon, Coronary; Chromium; Chromium Alloys; Coronary Stenosis; Drug Therapy, Combination; Drug-Eluting Stents; Everolimus; Humans; Platelet Aggregation Inhibitors; Platinum; Prospective Studies; Prosthesis Design; Republic of Korea; Research Design; Single-Blind Method; Sirolimus; Time Factors; Treatment Outcome

2012
A real all-comers randomized trial comparing Xience Prime and Promus Element stents.
    The Journal of invasive cardiology, 2013, Volume: 25, Issue:4

    Topics: Aged; Angina, Stable; Angina, Unstable; Chromium Alloys; Coronary Restenosis; Drug-Eluting Stents; Equipment Failure; Everolimus; Female; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platinum; Sirolimus; Thrombosis; Treatment Outcome

2013
Two-year safety and effectiveness of the platinum chromium everolimus-eluting stent for the treatment of small vessels and longer lesions.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2015, Feb-01, Volume: 85, Issue:2

    Topics: Aged; Cardiovascular Agents; Chromium; Coronary Artery Disease; Drug-Eluting Stents; Europe; Everolimus; Female; Humans; Japan; Male; Middle Aged; New Zealand; Percutaneous Coronary Intervention; Platinum; Prospective Studies; Prosthesis Design; Sirolimus; Time Factors; Treatment Outcome; United States

2015
Randomized comparison of acute stent malapposition between platinum-chromium versus cobalt-chromium everolimus-eluting stents.
    The international journal of cardiovascular imaging, 2015, Volume: 31, Issue:2

    Topics: Aged; Cardiovascular Agents; Chromium Alloys; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platinum; Prospective Studies; Prosthesis Design; Republic of Korea; Time Factors; Tomography, Optical Coherence; Treatment Outcome

2015
PLATINUM China: a prospective, randomized investigation of the platinum chromium everolimus-eluting stent in de novo coronary artery lesions.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2015, Volume: 85 Suppl 1

    Topics: Adult; Aged; Cardiovascular Agents; China; Chromium; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platinum; Prospective Studies; Prosthesis Design; Single-Blind Method; Time Factors; Treatment Outcome

2015
Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:7

    Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Resistance, Neoplasm; Erlotinib Hydrochloride; Everolimus; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Platinum; Prognosis; Salvage Therapy; Survival Rate

2015
Early vascular healing after titanium-nitride-oxide-coated stent versus platinum-chromium everolimus-eluting stent implantation in patients with acute coronary syndrome.
    The international journal of cardiovascular imaging, 2016, Volume: 32, Issue:7

    Topics: Acute Coronary Syndrome; Aged; Chromium; Coated Materials, Biocompatible; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Finland; Fractional Flow Reserve, Myocardial; Humans; Hyperplasia; Male; Microcirculation; Middle Aged; Neointima; Nitric Oxide; Percutaneous Coronary Intervention; Platinum; Prospective Studies; Single-Blind Method; Time Factors; Titanium; Tomography, Optical Coherence; Treatment Outcome; Vascular Resistance; Vasodilator Agents; Wound Healing

2016
Twelve-month results of a prospective, multicentre trial to assess the everolimus-eluting coronary stent system (PROMUS Element): the PLATINUM PLUS all-comers randomised trial.
    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2017, Jan-20, Volume: 12, Issue:13

    Topics: Adult; Aged; Aged, 80 and over; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platinum; Prospective Studies; Treatment Outcome

2017
Outcomes of patients treated with durable polymer platinum-chromium everolimus-eluting stents: a meta-analysis of randomised trials.
    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2017, Oct-20, Volume: 13, Issue:8

    Topics: Aged; Chromium; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platinum; Polymers; Treatment Outcome

2017
A randomised comparison of biodegradable polymer- and permanent polymer-coated platinum-chromium everolimus-eluting coronary stents in China: the EVOLVE China study.
    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2017, Nov-20, Volume: 13, Issue:10

    Topics: Adolescent; Adult; Aged; China; Chromium; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platinum; Polymers; Sirolimus; Treatment Outcome; Young Adult

2017
Long-Term Safety and Efficacy of Platinum Chromium Everolimus-Eluting Stents in Coronary Artery Disease: 5-Year Results From the PLATINUM Trial.
    JACC. Cardiovascular interventions, 2017, 12-11, Volume: 10, Issue:23

    Topics: Aged; Asia; Cardiovascular Agents; Chromium Alloys; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Europe; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platinum; Proportional Hazards Models; Prosthesis Design; Risk Factors; Time Factors; Treatment Outcome; United States

2017
Long-Term Comparison of Platinum Chromium Everolimus-Eluting Stent vs. Cobalt Chromium Zotarolimus-Eluting Stent - 3-Year Outcomes From the HOST-ASSURE Randomized Clinical Trial.
    Circulation journal : official journal of the Japanese Circulation Society, 2019, 06-25, Volume: 83, Issue:7

    Topics: Aged; Chromium; Chromium Alloys; Coronary Angiography; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platinum; Prospective Studies; Prosthesis Failure; Sirolimus

2019
A Phase II Trial of Everolimus in Patients with Advanced Pancreatic Neuroendocrine Carcinoma Refractory or Intolerant to Platinum-Containing Chemotherapy (NECTOR Trial).
    Neuroendocrinology, 2020, Volume: 110, Issue:11-12

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Neuroendocrine; Drug-Related Side Effects and Adverse Reactions; Everolimus; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Pancreatic Neoplasms; Platinum; Progression-Free Survival; Prospective Studies

2020
Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomised trial.
    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2022, Apr-22, Volume: 17, Issue:18

    Topics: Absorbable Implants; Chromium; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platinum; Polymers; Treatment Outcome

2022

Other Studies

21 other study(ies) available for platinum and everolimus

ArticleYear
Strut tissue coverage and endothelial cell coverage: a comparison between bare metal stent platforms and platinum chromium stents with and without everolimus-eluting coating.
    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2010, Volume: 6, Issue:5

    Topics: Angioplasty, Balloon, Coronary; Animals; Chromium; Coronary Vessels; Drug-Eluting Stents; Endothelial Cells; Everolimus; Female; Immunosuppressive Agents; Metals; Microscopy, Electron, Scanning; Platelet Endothelial Cell Adhesion Molecule-1; Platinum; Prosthesis Design; Rabbits; Sirolimus; Stents

2010
PLATINUM QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenoses.
    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2011, Volume: 7, Issue:1

    Topics: Aged; Angioplasty, Balloon, Coronary; Chromium; Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Platinum; Prospective Studies; Sirolimus; Ultrasonography, Interventional

2011
Initial clinical experience with an everolimus eluting platinum chromium stent (Promus Element) in unselected patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
    International journal of cardiology, 2013, Jul-15, Volume: 167, Issue:1

    Topics: Aged; Angioplasty, Balloon, Coronary; Chromium; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Platinum; Registries; Sirolimus; Sweden; Treatment Outcome

2013
Longitudinal compression of the platinum-chromium everolimus-eluting stent during coronary implantation: predisposing mechanical properties, incidence, and predictors in a large patient cohort.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2013, Volume: 81, Issue:5

    Topics: Aged; Cardiovascular Agents; Chi-Square Distribution; Chromium; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Equipment Failure Analysis; Everolimus; Female; Humans; Logistic Models; Male; Materials Testing; Middle Aged; Multivariate Analysis; Odds Ratio; Percutaneous Coronary Intervention; Platinum; Prosthesis Design; Prosthesis Failure; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Stress, Mechanical; Tomography, Optical Coherence; Treatment Outcome

2013
Fate of side-branch jailing and a malapposed platinum marker after resorption of an everolimus-eluting bioresorbable vascular scaffold: serial optical coherence tomography observations.
    JACC. Cardiovascular interventions, 2015, Volume: 8, Issue:3

    Topics: Absorbable Implants; Angina, Stable; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Vessels; Everolimus; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platinum; Predictive Value of Tests; Prosthesis Design; Time Factors; Tomography, Optical Coherence; Treatment Outcome

2015
Comparison of platinum chromium everolimus-eluting stent with cobalt chromium everolimus-eluting stent in unselected patients undergoing percutaneous coronary intervention.
    European review for medical and pharmacological sciences, 2015, Volume: 19, Issue:12

    Topics: Aged; Chromium; Cobalt; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platinum; Radiography; Treatment Outcome

2015
Incidence and Clinical Impact of Stent Fracture After PROMUS Element Platinum Chromium Everolimus-Eluting Stent Implantation.
    JACC. Cardiovascular interventions, 2015, Aug-17, Volume: 8, Issue:9

    Topics: Aged; Aged, 80 and over; Cardiovascular Agents; Chromium; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Everolimus; Female; Humans; Incidence; Japan; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Percutaneous Coronary Intervention; Platinum; Prosthesis Design; Prosthesis Failure; Risk Factors; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Ultrasonography, Interventional

2015
Unintentional extraction of a platinum-chromium everolimus-eluting stent by entanglement with a covered stent.
    European heart journal, 2016, Apr-01, Volume: 37, Issue:13

    Topics: Aged; Chromium; Coronary Angiography; Coronary Stenosis; Device Removal; Drug-Eluting Stents; Everolimus; Humans; Immunosuppressive Agents; Male; Platinum; Vascular Calcification

2016
Dual mTORC1/2 Inhibition as a Novel Strategy for the Resensitization and Treatment of Platinum-Resistant Ovarian Cancer.
    Molecular cancer therapeutics, 2016, Volume: 15, Issue:7

    Topics: Allosteric Regulation; Animals; Antineoplastic Agents; Carboplatin; Catalytic Domain; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Drug Resistance, Neoplasm; Everolimus; Female; Humans; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Multiprotein Complexes; Ovarian Neoplasms; Platinum; Protein Kinase Inhibitors; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2016
Three-month evaluation of strut healing using a novel optical coherence tomography analytical method following bioresorbable polymer everolimus-eluting stent implantation in humans: the TIMELESS study.
    Coronary artery disease, 2017, Volume: 28, Issue:2

    Topics: Absorbable Implants; Acute Coronary Syndrome; Aged; Cardiovascular Agents; Chromium; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Coronary Vessels; Drug Therapy, Combination; Drug-Eluting Stents; Everolimus; Female; Humans; Lactic Acid; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platinum; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Predictive Value of Tests; Prosthesis Design; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Wound Healing

2017
The Promus Premier everolimus-eluting platinum chromium stent with durable polymer evaluated in a real world all-comer population in Rotterdam cardiology hospital (the P-SEARCH registry).
    International journal of cardiology, 2017, Aug-01, Volume: 240

    Topics: Aged; Angina, Stable; Chromium; Cohort Studies; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Netherlands; Percutaneous Coronary Intervention; Platinum; Polymers; Prospective Studies; Registries

2017
Real-life clinical outcomes with everolimus eluting platinum chromium stent with an abluminal biodegradable polymer in patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2017, Nov-15, Volume: 90, Issue:6

    Topics: Absorbable Implants; Aged; Angioplasty, Balloon, Coronary; Chromium; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Male; Platinum; Polymers; Postoperative Complications; Proportional Hazards Models; Prosthesis Design; Registries; Retrospective Studies; Survival Rate; Sweden; Time Factors; Treatment Outcome

2017
Race/Ethnicity-Based Outcomes in Cardiovascular Medicine.
    JAMA cardiology, 2017, 12-01, Volume: 2, Issue:12

    Topics: Drug-Eluting Stents; Ethnicity; Everolimus; Female; Humans; Male; Platinum; White People

2017
Predictors and Long-Term Clinical Outcome of Longitudinal Stent Deformation: Insights From Pooled Analysis of Korean Multicenter Drug-Eluting Stent Cohort.
    Circulation. Cardiovascular interventions, 2017, Volume: 10, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Agents; Chromium Alloys; Coronary Angiography; Coronary Artery Disease; Databases, Factual; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platinum; Prosthesis Design; Prosthesis Failure; Republic of Korea; Risk Factors; Sirolimus; Time Factors; Treatment Outcome; Ultrasonography, Interventional

2017
Comparison of clinical outcomes of coronary artery stent implantation in patients with end-stage chronic kidney disease including hemodialysis for three everolimus eluting (EES) stent designs: Bioresorbable polymer-EES, platinum chromium-EES, and cobalt c
    Journal of interventional cardiology, 2018, Volume: 31, Issue:2

    Topics: Absorbable Implants; Aged; Chromium; Cobalt; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Male; Middle Aged; Percutaneous Coronary Intervention; Platinum; Renal Dialysis; Risk Factors; Trace Elements; Treatment Outcome

2018
Clinical outcomes in unselected patients treated with the PROMUS Element platinum-chromium, everolimus-eluting stent: Final five-year results from the PE PROVE Study.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2019, 02-15, Volume: 93, Issue:3

    Topics: Cardiovascular Agents; Chromium; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Europe; Everolimus; Female; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Platinum; Prospective Studies; Prosthesis Design; Registries; Risk Factors; Time Factors; Treatment Outcome

2019
The Pt-Cr everolimus-eluting stent with bioabsorbable polymer in the treatment of patients with acute coronary syndromes. Results from the SYNERGY ACS registry.
    Cardiovascular revascularization medicine : including molecular interventions, 2019, Volume: 20, Issue:8

    Topics: Absorbable Implants; Acute Coronary Syndrome; Aged; Aged, 80 and over; Angina, Unstable; Cardiovascular Agents; Chromium; Coronary Thrombosis; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Non-ST Elevated Myocardial Infarction; Percutaneous Coronary Intervention; Platinum; Prosthesis Design; Recurrence; Registries; Retrospective Studies; Risk Factors; Spain; ST Elevation Myocardial Infarction; Time Factors; Treatment Outcome

2019
Small-vessel PCI outcomes in men, women, and minorities following platinum chromium everolimus-eluting stents: Insights from the pooled PLATINUM Diversity and PROMUS Element Plus Post-Approval studies.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2019, Jul-01, Volume: 94, Issue:1

    Topics: Aged; Cardiovascular Agents; Chromium; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Everolimus; Female; Health Status Disparities; Humans; Male; Middle Aged; Minority Health; Myocardial Infarction; Observational Studies as Topic; Percutaneous Coronary Intervention; Platinum; Prosthesis Design; Race Factors; Registries; Retrospective Studies; Risk Factors; Sex Factors; Time Factors; Treatment Outcome; United States

2019
Assessment of strut coverage of everolimus-eluting platinum chromium stent 2 weeks after implantation by optical coherence tomography.
    Heart and vessels, 2019, Volume: 34, Issue:8

    Topics: Absorbable Implants; Aged; Cardiovascular Agents; Chromium; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Humans; Japan; Male; Middle Aged; Neointima; Percutaneous Coronary Intervention; Platinum; Polyesters; Prospective Studies; Prosthesis Design; Tomography, Optical Coherence

2019
Final 5-Year Results in Unselected Patients Implanted With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent (from the PROMUS Element Plus US Post-Approval Study).
    The American journal of cardiology, 2019, 06-01, Volume: 123, Issue:11

    Topics: Chromium; Combined Modality Therapy; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Platinum; Prospective Studies; Prosthesis Design; Time Factors; Treatment Outcome; United States

2019
Prasugrel Monotherapy After Percutaneous Coronary Intervention With Biodegradable-Polymer Platinum-Chromium Everolimus Eluting Stent for Japanese Patients With Chronic Coronary Syndrome (ASET-JAPAN).
    Circulation journal : official journal of the Japanese Circulation Society, 2023, 05-25, Volume: 87, Issue:6

    Topics: Aspirin; Drug-Eluting Stents; East Asian People; Everolimus; Hemorrhage; Humans; Japan; Percutaneous Coronary Intervention; Pilot Projects; Platinum; Polymers; Prasugrel Hydrochloride; Prospective Studies

2023